myQA iON; Article Number: MQ10-000;
Class I - DangerousWhat Should You Do?
- Check if you have this product: Article Number: MQ10-000; UDI-DI: EIBAMQ010000;
- Do not eat it: Even if it looks and smells fine, do not consume this product.
- Throw it away or return it: You can return the product to the store for a full refund.
- Seek medical attention if needed: If you've consumed this product and feel unwell, contact your doctor immediately.
- Report problems: Report any issues to the FDA's Safety Reporting Portal.
⚠️ Emergency: If you experience severe symptoms after consuming this product, call 911 or Poison Control at 1-800-222-1222.
Recall Details
- Company:
- IBA Dosimetry GmbH
- Reason for Recall:
- Wrong analysis results can occur if the user creates two structures with the same name, except for one differing by a special character.
- Classification:
- Class I - Dangerous
Dangerous or defective products that predictably could cause serious health problems or death.
- Status:
- ongoing
Product Information
Full Description:
myQA iON; Article Number: MQ10-000;
Product Codes/Lot Numbers:
Article Number: MQ10-000; UDI-DI: EIBAMQ010000;
Official Source
Always verify recall information with the official FDA source:
View on FDA.govFDA Recall Number: Z-1703-2025
Related Recalls
IBA Dosimetry GmbH Lift Table Type 4320, Catalog HA03-010#2 and HA03-000#2
Iba Dosimetry Gmbh
When the electric lift table is connected to the mains power, in a very rare occasion, the table may start to move up in an uncontrolled manner.
COMPASS SW Version 3.1, Catalog Number CS10-100, medical linear accelerator, radiological
Iba Dosimetry Gmbh
Error in the software. During internal tests of the current development version of the Compass SW it was found that dose reconstruction for DMLC plans when the jaws move or mlc leaves reverse during beam on will not be scaled correctly for all control points.
COMPASS, Model No. SW Version 3.1, catalogue number CS10-100 (medical Linear accelerator) radiological
Iba Dosimetry Gmbh
Error in the software. A deviation between reconstructed and planned dose distribution may not be detected prior to treatment and this can result in an over or under-estimation of the pretreatment delivered dose.